HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G/Gillette merger

This article was originally published in The Rose Sheet

Executive Summary

Federal Trade Commission is seeking additional information from the companies as it conducts a review of the proposed $57 bil. merger, Procter & Gamble reports. "A request of this nature is typical in a transaction of this size," firm notes. Announced in January, the deal already is facing several challenges. Gillette shareholders filed a putative class action lawsuit in Delaware state court Feb. 10 alleging the proposed merger is "unduly favorable" to P&G. Plaintiffs are seeking injunctive relief halting consummation of the merger or rescission following its consummation, as well as compensatory damages (1"The Rose Sheet" March 21, 2005, In Brief). In addition, Massachusetts Secretary of the Commonwealth William Galvin recently launched an investigation into Gillette CEO James Kilts' compensation package under the deal, and has expanded the inquiry to include proposed benefits for Gillette retirees (2"The Rose Sheet" Feb. 7, 2005, p. 8 and 3"The Rose Sheet" Feb. 28, 2005, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel